MEND Technology (855-445-3971) announces an update to its programmable frequency specific microcurrent (FSM) device designed to support practitioners managing chronic pain with customizable therapy.
-- MEND Technology has announced an update to its programmable frequency specific microcurrent (FSM) device, providing licensed healthcare practitioners with a more targeted approach to managing acute and chronic pain in patients.
More information about the device is available at https://mendtechnology.com/
Chronic pain affects 51.6 million adults in the United States, according to the CDC. For many patients, conventional treatments such as physical therapy and medication provide limited relief. As a result, some practitioners are incorporating FSM therapy as a non-pharmacological option for conditions affecting the back, knees, shoulders, elbows, and other musculoskeletal areas.
FSM therapy delivers electrical current at approximately one-millionth of an ampere to targeted tissues. Research published in the Journal of Bodywork and Movement Therapies reported a 3.8-fold reduction in pain intensity among patients with chronic low back pain treated with FSM. In that study, 90% of participants had not responded to prior treatments, including physical therapy, chiropractic care, and drug therapy.
The updated MEND Professional device features dual-channel output and stores up to 999 customizable treatment protocols. Practitioners can program frequency pairs tailored to each patient’s condition and anatomy, allowing targeted therapy delivery, and a manual mode also enables real-time frequency adjustments during treatment sessions.
The devices are available in professional units intended for clinical use and wellness-focused configurations designed for non-clinical environments. Each portable device features a large, backlit display and supports customized therapy settings.
Practitioners can store and manage protocols directly on the device, enabling the efficient application of frequently used frequency combinations during clinical sessions.
All MEND devices are regulated by the FDA as transcutaneous electrical nerve stimulators and manufactured under ISO 13485:2016 and CFR 21 Part 820 quality standards, explains the team. Devices are available to licensed healthcare practitioners through a verified account system.
"The MEND Professional gives practitioners the ability to customize treatment for each patient’s specific condition and anatomy," a MEND Technology spokesperson said. “Whether addressing back pain, knee injuries, or shoulder dysfunction, the device delivers frequency specific therapy to targeted areas," they added.
Additional information about the device is available at https://mendtechnology.com/
Contact Info:
Name: Sheila Flores
Email: Send Email
Organization: MEND Technology
Address: 6715 NE 63rd St Ste 103 PMB 120, Vancouver, Washington 98661, United States
Website: https://mendtechnology.com
Source: NewsNetwork
Release ID: 89186364
Should any errors, concerns, or inconsistencies arise from the content provided in this press release that require attention or if a press release needs to be taken down, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for timely assistance within 8 hours – taking necessary measures to rectify identified issues or providing guidance on the removal process. We prioritize delivering accurate and reliable information.
